TriSalus Life Sciences Inc. (TLSI)
NASDAQ · Healthcare
TriSalus Life Sciences Inc. Revenue 2022–2025
TriSalus Life Sciences Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- TriSalus Life Sciences Inc. revenue for the quarter ending March 31, 2026 was 8.9 M, a 2.92% decrease year-over-year.
- TriSalus Life Sciences Inc. revenue for the twelve months ending March 31, 2026 was 40.8 M, a 54.93% increase year-over-year.
- TriSalus Life Sciences Inc. annual revenue for 2025 was 45.2 M, a 53.41% increase from 2024.
- TriSalus Life Sciences Inc. annual revenue for 2024 was 29.4 M, a 58.99% increase from 2023.
- TriSalus Life Sciences Inc. annual revenue for 2023 was 18.5 M, a 49.31% increase from 2022.
- TriSalus Life Sciences Inc. annual revenue for 2022 was 12.4 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TriSalus Life Sciences Inc. Revenue — FAQ
TriSalus Life Sciences Inc. (TLSI) revenue over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is TriSalus Life Sciences Inc.'s revenue?
TriSalus Life Sciences Inc. (TLSI) reported revenue of $45M for fiscal 2025.
Where can I see TLSI's revenue history?
The chart and table above show TriSalus Life Sciences Inc.'s revenue by year and by quarter, including the growth rate.